Insight into the Evolving Role of PCSK9
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is the last discovered member of the family of proprotein convertases (PCs), mainly synthetized in hepatic cells. This serine protease plays a pivotal role in the reduction of the number of low-density lipoprotein receptors (LDLRs) on the surface...
Main Authors: | Mateusz Maligłówka, Michał Kosowski, Marcin Hachuła, Marcin Cyrnek, Łukasz Bułdak, Marcin Basiak, Aleksandra Bołdys, Grzegorz Machnik, Rafał Jakub Bułdak, Bogusław Okopień |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-03-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/3/256 |
Similar Items
-
Pleiotropic Effects of PCSK-9 Inhibitors
by: Marcin Basiak, et al.
Published: (2021-03-01) -
The Effect of PCSK9 Inhibition on the Stabilization of Atherosclerotic Plaque Determined by Biochemical and Diagnostic Imaging Methods
by: Marcin Basiak, et al.
Published: (2023-08-01) -
Inclisiran—A Revolutionary Addition to a Cholesterol-Lowering Therapy
by: Adrianna Dec, et al.
Published: (2023-04-01) -
Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia
by: Marcin Basiak, et al.
Published: (2022-05-01) -
Impact of PCSK9 Inhibition on Proinflammatory Cytokines and Matrix Metalloproteinases Release in Patients with Mixed Hyperlipidemia and Vulnerable Atherosclerotic Plaque
by: Marcin Basiak, et al.
Published: (2022-06-01)